Surgicel® (Fibrillar) in Non-variceal UGI Bleeding
Not Applicable
- Conditions
- Non-variceal Upper Gastrointestinal Bleeding
- Interventions
- Drug: Surgicel
- Registration Number
- NCT02054260
- Lead Sponsor
- Soonchunhyang University Hospital
- Brief Summary
The aim of this study is to assess of effect of Surgicel® (Fibrillar) for preventing delayed bleeding after endoscopic hemostasis in non-variceal upper gastrointestinal bleeding
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Patients with non variceal upper gastrointestinal bleeding proven by esophagogastroduodenoscopy
- Patients with active bleeding (Forrest classification Ia or Ib or IIa)
Exclusion Criteria
- Patients with upper gastrointestinal tract malignancy
- Patients with acute severe illness
- Coagulopathy: liver cirrhosis, thrombocytopenia
- Pregnant women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Surgicel add therapy Surgicel -
- Primary Outcome Measures
Name Time Method Rebleeding rate at the second look endoscopy 2 year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Digestive Disease Center and Research Institute, Department of Internal Medicine, Soonchunhyang University College of Medicine
🇰🇷Bucheon, Korea, Republic of